Associate Members

Ian Davison graduated from Kent University (Canterbury, England) with a BSc 1st class honours degree in chemistry (1979). He worked as a research chemist at Roche Products Ltd. (England) for 17 months on their anti-cancer radio-sensitiser program (1980-81). He then carried out postgraduate research in the synthetic and physical organic chemistry of liquid crystals leading to a PhD degree (1981-84, London). After a short period of postdoctoral research on the immobilisation of enzymes in copolymer micelles at Imperial College, London University, he worked on Major Systems Procurement contracts on behalf of the British Telecom Research Laboratories for 12 months (1986). Ian joined Genzyme in 1987 to work on process research, development and scale-up of organic chemical intermediates and pharmaceutical products. Since then, he continued to work in chemical development with Genzyme then Sanofi at the same site (Haverhill, UK) taking on positions of increasing responsibility culminating in the role of Site Head of Chemistry & Biotechnology Development (C&BD, 2015 – 2017). Ian had oversight of projects involving various subject areas such as:

• PAT enabled continuous manufacture of both small molecule and polymeric active pharmaceutical ingredients (APIs)
• Pharmaceutical API process improvement and life cycle management
• Multivariate data analysis and SPC
• QbD
• Quality risk management
• Process and analytical validation
• Regulatory support activities including process control strategy creation for continuous manufacturing processes
• Hydrogel polymer and small molecule characterisation
• DoE directed design of a new polymeric API entity

Following the closure of the Haverhill C&BD unit in 2017, Ian assumed the role of Principal Scientist for the site, providing scientific support and advice across multiple projects and disciplines. Ian left Sanofi in December 2018 and is now acting as a consultant to provide PAT training and support with a particular focus on pharmaceutical bioprocessing.